GB202113104D0 - Antagonist of pcsk9 - Google Patents
Antagonist of pcsk9Info
- Publication number
- GB202113104D0 GB202113104D0 GBGB2113104.0A GB202113104A GB202113104D0 GB 202113104 D0 GB202113104 D0 GB 202113104D0 GB 202113104 A GB202113104 A GB 202113104A GB 202113104 D0 GB202113104 D0 GB 202113104D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pcsk9
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2113104.0A GB202113104D0 (en) | 2021-09-14 | 2021-09-14 | Antagonist of pcsk9 |
EP22789482.1A EP4402263A2 (en) | 2021-09-14 | 2022-09-13 | Treatment of cardiovascular disease |
PCT/EP2022/075355 WO2023041508A2 (en) | 2021-09-14 | 2022-09-13 | Treatment of cardiovascular disease |
CA3229020A CA3229020A1 (en) | 2021-09-14 | 2022-09-13 | Treatment of cardiovascular disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2113104.0A GB202113104D0 (en) | 2021-09-14 | 2021-09-14 | Antagonist of pcsk9 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202113104D0 true GB202113104D0 (en) | 2021-10-27 |
Family
ID=78149336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2113104.0A Ceased GB202113104D0 (en) | 2021-09-14 | 2021-09-14 | Antagonist of pcsk9 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202113104D0 (en) |
-
2021
- 2021-09-14 GB GBGB2113104.0A patent/GB202113104D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2594788B (en) | Antagonist of PCSK9 | |
IL277127A (en) | Use of pcsk9 inhibitor for reducing cardiovascular risk | |
IL279363A (en) | Pcsk9 antagonist compounds | |
ZA202205938B (en) | Small molecule inhibitors of kras g12c mutant | |
IL281939A (en) | Inhibitors of vap-1 | |
IL284640A (en) | Pcsk9 inhibitors and methods of use thereof | |
IL287751A (en) | Kcnt1 inhibitors and methods of use | |
IL287768A (en) | Kcnt1 inhibitors and methods of use | |
IL284661A (en) | Pcsk9 inhibitors and methods of use thereof | |
EP3609882A4 (en) | Heterocyclic inhibitors of pcsk9 | |
IL281815A (en) | Inhibitors of vap-1 | |
IL292860A (en) | Allosteric egfr inhibitors and methods of use thereof | |
SG11202109781QA (en) | Uses of phosphodiesterase inhibitors | |
IL284570A (en) | Quinoline compounds as inhibitors of tam and met kinases | |
GB201810746D0 (en) | Use of sclerostin antagonist | |
GB201918463D0 (en) | Plumbing fixture and methods of operation | |
GB202113104D0 (en) | Antagonist of pcsk9 | |
GB202020553D0 (en) | Antagonist of pcsk9 | |
GB202013998D0 (en) | Antagonist of pcsk9 | |
GB202003756D0 (en) | Antagonist of PCSK9 | |
GB2589398B (en) | Compounds and methods of use | |
GB202215863D0 (en) | Preparation of neosaxitoxin | |
ZA202105399B (en) | Use of spiropidion | |
EP3968994C0 (en) | Abhd12 inhibitors and methods of making and using same | |
KR102423280B9 (en) | Sot-mram area-optimized design of sot-mram |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |